CClinicalTrials.gg
Active, not recruitingNCT05159804Updated Jan 6, 2022

Association Between Carotid Plaque Length and Cardiovascular Events

An observational study in Coronary Arteriosclerosis, sponsored by Changhai Hospital. Active, not recruiting at 5 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2022-01-06.

Sponsored by Changhai Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
3,637
Ages
18 Years and older
Sex
All
01

Study summary

This multicenter study involved 5 hospitals (Changhai Hospital; Yueyang Hospital of Shanghai University of Traditional Chinese Medicine; Gongli Hospital; Putuo Hospital of Shanghai University of Traditional Chinese Medicine; No. 904 Hospital of the PLA Joint Logistics Support Force Wuxi). The study enrolled 3637 patients with coronary atherosclerosis who were confirmed by coronary angiography from January 2017 through December 2018.

Read the detailed description

Patients with coronary atherosclerosis who were confirmed by coronary angiography were eligible for the study. Carotid ultrasonography was simultaneously performed, and carotid intima-media thickness (IMT), maximum thickness and length of all plaques were measured.

02

Conditions studied

  • Coronary Arteriosclerosis

Keywords

  • Carotid Artery Ultrasound
  • Carotid Plaque
  • Coronary Artery Disease
03

In context

Arteriosclerosis

317 studies on the registry are indexed under Arteriosclerosis; 33 are open to participants now.

This study's enrollment of 3,637 is above the median of 330 across 99 observational studies indexed under Arteriosclerosis.

Browse Arteriosclerosis studies →

Lead sponsor

Changhai Hospital is the lead sponsor of 342 studies on the registry; 133 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients hospitalized for coronary angiography and underwent carotid ultrasonography simultaneously

Inclusion criteria

  • Patients≥18 years old, those who underwent carotid ultrasonography and first coronary angiography simultaneously.

Exclusion criteria

Exclusion Criteria:

  • Patients with known coronary artery disease, previous coronary or carotid revascularization, missing carotid ultrasound or coronary angiography results.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
3,637 participants (actual)
Patient registry
No

Groups and cohorts

  • Carotid plaque length

    Patients underwent coronary angiography and carotid ultrasonography simultaneously

06

What researchers measure

Primary outcomes

  1. Major adverse cardiovascular events

    A composite of cardiovascular death, myocardial infarction, and stroke

    Time frame: 3 years

Secondary outcomes

  1. Incident cardiovascular events

    A composite of cardiovascular death, myocardial infarction, stroke, and unplanned coronary artery revascularization

    Time frame: 3 years

07

Study locations

5 sites
  • No. 904 Hospital of the PLA Joint Logistics Support Force
    Wuxi, Jiangsu 214000, China
  • Changhai Hospital
    Shanghai, Shanghai 200000, China
  • Gongli Hospital
    Shanghai, Shanghai 200000, China
  • Putuo Hospital
    Shanghai, Shanghai 200000, China
  • Yueyang Hospital
    Shanghai, Shanghai 200000, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05159804
Lead sponsor
Changhai Hospital
Collaborators
Putuo Hospital, Shanghai University of Traditional Chinese Medicine, No. 904 Hospital of the PLA Joint Logistics Support Force, Gongli Hospital, Yueyang Hospital, Shanghai University of Traditional Chinese medicine
Responsible party
Pan Li (Clinical Professor, Changhai Hospital) — Principal investigator
First posted
Dec 16, 2021
Start date
Jan 1, 2017
Primary completion
Jun 30, 2021
Completion
Dec 30, 2030 (estimated)
Last update
Jan 6, 2022

Study contacts

Pan Li, PhD
principal investigator · Changhai Hospital
Jian Na, MD
study director · Putuo Hospital
Liang Chen, MD
study director · No. 904 Hospital of the PLA Joint Logistics Support Force
Wei Zhang, MD
study director · Gongli Hospital
Yawei Yang, MD
study director · Yueyang Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion